Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by CalgaryATEon Dec 10, 2020 4:29pm
125 Views
Post# 32080861

RE:RE:RE:RE:Update

RE:RE:RE:RE:Update
MrMugsy wrote:
Ryeman40 wrote: Somebody asked about corporate update on biopub at the end and Dan said somewhere middle of January.  I wonder if they'll have anything on possible meetings from JP Morgan conference. 


Ryeman ... if my notes are correct, someone asked about employees and any additional hirings.
I thought Dan said that they've done the hirings but that more information would be available with the corporate update by mid-January.  It almost made me think he'd be jockeying the board to create one more company position as he did in the past - but - that's just a guess.

Might have read that wrong ... but that's how it hit me.  Will need to listen to the recorded BioPUB when it's released.

I wouldn't expect anything from J.P.Morgan except a video/presentation if they are presenting.  If it's one-on-one meetings, we probably won't hear anything.

JMO.


I asked something to the effect of:  "Has Antibe hired the new Business Development Officer to lead negotiations for partnering?  Also, is Dan allowed to say when the comprehensive corporate update will be released?"

I asked those questions, because they had been inverviewing for the BDO back in October (and I figured that hiring would be a small mini-catalyst of slow upward growth in the SP).  I also asked about the comprehensive corporate update as they said in the "coming weeks" in the Nov. 13th Financials newsrelase (4 weeks ago).

I'm not sure if I confused Dan with combining the 2 questions, or if Dan was trying to think on the fly if his answer might be material news and was being careful, but he answered the BDO question fairly incoherently (I'll have to rewatch it once the Biopub is posted), something to the effect:

In regards to the hiring of the Buisness Development Officer, he sort of rambled and mentioned "ink" or "inking" twice.  I got the general impression that they had not hired the BDO, but were close to signing (inking) a contract with someone.  Perhaps why partnering discussions would really start to heat up in January?  Antibe finally getting around to hiring the guy who was going to lead the partnering disccusions (though he did say that partnering discussions had commenced).

The comprehensive corporate update response he said January (can't remember if he said "mid January" like someone else said, or just "January"). 
<< Previous
Bullboard Posts
Next >>